NIR-triggered high-efficient photodynamic and chemo-cascade therapy using caspase-3 responsive functionalized upconversion nanoparticles

Biomaterials. 2017 Oct:141:40-49. doi: 10.1016/j.biomaterials.2017.06.031. Epub 2017 Jun 23.

Abstract

Stimuli-responsive nanoparticles with multiple therapeutic/diagnostic functions are highly desirable for effective tumor treatment. Herein novel caspase-3 responsive functionalized upconversion nanoparticles (CFUNs) were fabricated with three-in-one functional integration: near-infrared (NIR) triggered photodynamic damage along with caspase-3 activation, subsequent caspase-3 responsive drug release, and cascade chemotherapeutic activation. CFUNs were formulated from the self-assembly of caspase-3 responsive doxorubicin (DOX) prodrug tethered with DEVD peptide (DEVD-DOX), upconversion nanoparticles (UCNP), a photosensitizer (pyropheophorbide-a methyl ester, MPPa), and tumor-targeting cRGD-PEG-DSPE to afford multifunctional CFUNs, MPPa/UCNP-DEVD-DOX/cRGD. Upon cellular uptake and NIR irradiation, the visible light emission of UCNP could excite MPPa to produce reactive oxygen species for photodynamic therapy (PDT) along with the activation of caspase-3, which further cleaved DEVD peptide to release DOX within tumor cells, thus accomplishing NIR-triggered PDT and cascade chemotherapy. CFUNs presented silent therapeutic potency and negligible cytotoxicity in the dark, whereas in vitro and in vivo experiments demonstrated the NIR-triggered cascade therapeutic activation and tumor inhibition due to consecutive PDT and chemotherapy. Current NIR-activated cascade tumor therapy with two distinct mechanisms is significantly favorable to overcome multidrug resistance and tumor heterogeneity for persistent tumor treatment.

Keywords: Cascade chemotherapy; Caspase-3; NIR; Photodynamic therapy; Upconversion nanoparticles.

MeSH terms

  • Animals
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / therapeutic use
  • Caspase 3 / metabolism*
  • Cell Line, Tumor
  • Delayed-Action Preparations / metabolism*
  • Doxorubicin / administration & dosage*
  • Doxorubicin / therapeutic use
  • Drug Delivery Systems
  • Female
  • Humans
  • Infrared Rays
  • Mice, Inbred BALB C
  • Nanoparticles / metabolism*
  • Neoplasms / drug therapy*
  • Neoplasms / metabolism
  • Neoplasms / pathology
  • Peptides, Cyclic / metabolism
  • Phosphatidylethanolamines / metabolism
  • Photochemotherapy
  • Photosensitizing Agents / administration & dosage*
  • Photosensitizing Agents / therapeutic use
  • Polyethylene Glycols / metabolism
  • Porphyrins / administration & dosage*
  • Porphyrins / therapeutic use
  • Reactive Oxygen Species / metabolism

Substances

  • Antineoplastic Agents
  • Delayed-Action Preparations
  • Peptides, Cyclic
  • Phosphatidylethanolamines
  • Photosensitizing Agents
  • Porphyrins
  • Reactive Oxygen Species
  • cyclic arginine-glycine-aspartic acid peptide
  • polyethylene glycol-distearoylphosphatidylethanolamine
  • pyropheophorbide-a methylester
  • Polyethylene Glycols
  • Doxorubicin
  • Caspase 3